AG&M - Re-generation and cancer of the digestive system

Activities 2017 2018

‘Translating antibody – effector cell cross-talk to immunotherapy’.

Marjolein van Egmond (Invited speaker)
17 Apr 201818 Apr 2018

Activity: Talk or presentationInvited talk

European Phagocyte Group (External organisation)

M van Egmond (Member)
2018

Activity: MembershipMembership of committee

thesis committee •J.P. Veluchamy

M van Egmond (Examiner)
2018

Activity: Examination

Developments in the classification of gastric cancer

Nicole van Grieken (Speaker)
21 Nov 2018

Activity: Talk or presentationInvited talk

member of the opposition A. Zaal

SJ van Vliet (Examiner)
2018

Activity: Examination

Thesis committee E. Heideveld, Sanquin (External organisation)

Marjolein van Egmond (Chair)
2018

Activity: MembershipMembership of committee

‘Immunoglobulin A: Trojan horse or magic bullet?’

M van Egmond (Invited speaker)
Jun 2018

Activity: Talk or presentationInvited talk

‘Immunoglobulin A; Trojan horse or magic bullet?’

Marjolein van Egmond (Keynote speaker)
21 Apr 2018

Activity: Talk or presentationInvited talk

‘Immunoglobulin A: Trojan horse or magic bullet?’

Marjolein van Egmond (Invited speaker)
12 Sep 2018

Activity: Talk or presentationInvited talk

‘Immunoglobulin A: Trojan horse or magic bullet?’

Marjolein van Egmond (Invited speaker)
6 Dec 2018

Activity: Talk or presentationInvited talk

‘Immunoglobulin A: Trojan horse or magic bullet?’

Marjolein van Egmond (Invited speaker)
14 Sep 2018

Activity: Talk or presentationInvited talk

Clinical relevance of molecular biomarkers in gastric cancer.

Nicole van Grieken (Speaker)
7 Jun 2018

Activity: Talk or presentationInvited talk

Gordon Research Conference ‘Antibody Biology and Engineering (Event)

M van Egmond (Chair)
2018

Activity: MembershipMembership of committee

‘Enlisting myeloid effectors cells in the fight against cancer’.

M van Egmond (Invited speaker)
Jan 2018

Activity: Talk or presentationInvited talk

‘Translating antibody – effector cell cross-talk to immunotherapy’.

Marjolein van Egmond (Invited speaker)
25 Feb 20182 Mar 2018

Activity: Talk or presentationInvited talk

‘Immunoglobulin A: Trojan horse or magic bullet?’

Marjolein van Egmond (Invited speaker)
11 Sep 2018

Activity: Talk or presentationInvited talk

5th European Congress of Immunology

M van Egmond (Organiser)
2018

Activity: Participating in or organising an eventOrganising a conference, workshop, ...

Translational research in gastrointestinal cancer.

Nicole van Grieken (Speaker)
18 Oct 2017

Activity: Talk or presentationInvited talk

Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy: a systematic review and meta-analysis.

SE van Oostendorp (Speaker), AKE Elfrink (Speaker), WAA Borstlap (Speaker), C. Sietses (Speaker), WJHJ Meijerink (Speaker), JB Tuynman (Speaker)
Dec 2017

Activity: Talk or presentationOral presentation

Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX in advanced pancreatic ductal adenocarcinoma

LL Meijer (Speaker), C Caparello (Speaker), TYS Le Large (Speaker), BM Zonderhuis (Speaker), F Daams (Speaker), E Giovannetti (Speaker), G Kazemier (Speaker)
May 2017

Activity: Talk or presentationOral presentation

Advanced imaging in HIPEC patients with peritoneal metastases of colorectal cancer

NR Sluiter (Speaker), SL Vlek (Speaker), HT Brandsma (Speaker), AR Wijsmuller (Speaker), NCT van Grieken (Speaker), G Kazemier (Speaker), JB Tuynman (Speaker)
10 Nov 2017

Activity: Talk or presentationOral presentation

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

NR Sluiter (Speaker), EMV de Cuba (Speaker), R Kwakman (Speaker), VMH Coupé (Speaker), JAM Belien (Speaker), GA Meijer (Speaker), EA te Velde (Speaker)
Mar 2017

Activity: Talk or presentationOral presentation

Time frame of clinical recovery in patients undergoing successful non-operative treatment for uncomplicated appendicitis; A retrospective analysis of a prospective cohort study.

M Knaapen (Speaker), J.H. van der Lee (Speaker), LWE van Heurn (Speaker), R Bakx (Speaker), RR Gorter (Speaker)
10 Nov 2017

Activity: Talk or presentationOral presentation

The correlation between baseline state anxiety and pain measurement six weeks after surgical correction of pectus excavatum patients.

WP Zuidema (Speaker), JWA Oosterhuis (Speaker), ESM de Lange-de Klerk (Speaker), R. van Baren (Speaker), AFW van der Steeg (Speaker), LWE van Heurn (Speaker)
17 May 2017

Activity: Talk or presentationOral presentation

Plasma microRNAs predict progression in patients with advanced pancreatic ductal adenocarcinoma treated with FOLFIRINOX chemotherapy

LL Meijer (Speaker), C Caparello (Speaker), TYS Le Large (Speaker), G Kazemier (Speaker), E Giovannetti (Speaker)
Jun 2017

Activity: Talk or presentationOral presentation

Rapid development of peritoneal metastases after adjuvant chemotherapy is associated with worse survival after cytoreduction and HIPEC.

NR Sluiter (Speaker), Y Salhi (Speaker), G Kazemier (Speaker), HMW Verheul (Speaker), JB Tuynman (Speaker)
Sep 2017

Activity: Talk or presentationOral presentation